Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 5 clinical trials
A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With GEP-NET (SORENTO)

The purpose of this study is to compare the effectiveness and safety of CAM2029 to octreotide LAR or lanreotide ATG in patients with advanced, well-differentiated GEP-NET. Patients who

  • 0 views
  • 08 Jun, 2022
  • 42 locations
LAnreotide in Metastatic Pheochromocytoma / PARAganglioma (LAMPARA)

The objectives of this study are: To assess the efficacy of lanreotide given every 4 weeks in participants with advanced or metastatic paraganglioma/ pheochromocytoma. To

metastatic disease
catecholamines
chromogranin a
pheochromocytoma
adrenal pheochromocytoma
  • 0 views
  • 24 Nov, 2021
  • 2 locations
A Trial Aiming to Assess the Safety and Activity of the Combination of Cabozantinib Plus Lanreotide in GEP and NET

A Phase II trial aiming to assess the safety and activity of the combination of cabozantinib plus lanreotide in gastroenteropancreatic (GEP) and thoracic neuroendocrine tumor (NET): The LOLA

intestinal neuroendocrine tumor
pancreatic net
liver metastasis
somatostatin
ki-67
  • 0 views
  • 12 Sep, 2021
  • 1 location
Real-World Study (RWS) of Lanreotide Autogel (LAN) for the Treatment of Patients With Acromegaly in China

This study aims to assess the one-year effectiveness and safety of LAN among patients with acromegaly in China in routine clinical practice. In addition, the study is designed to understand the real-world treatment patterns and outcomes of LAN among Chinese patients with acromegaly.

igf1
lanreotide
fasting
  • 0 views
  • 29 Jul, 2022
  • 1 location
Asian Investigation of Lanreotide Autogel® in the Management of GEP-NETs (AIM-NETs)

Lanreotide Autogel® has been established as a standard of care for patients with locally advanced or metastatic GEP-NETs based on the success of CLARINET trial. However, only few patients with

  • 0 views
  • 28 Jul, 2022
  • 1 location